Inherited myoclonus-dystonia: How many causative genes and clinical phenotypes?

Neurology

Volumn 59, Issue 8, 2002, Pages 1130-1131

  Furukawa, Yoshiaki ^a   Rajput, Ali H ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; SARCOGLYCAN;

ALLELE; CHROMOSOME 18P; CHROMOSOME 7Q; CLINICAL FEATURE; DYSTONIA; EDITORIAL; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOME IMPRINTING; HUMAN; INHERITANCE; MISSENSE MUTATION; MYOCLONUS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0037159249     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.8.1130     Document Type: Editorial

References (19)

1. Gasser T. Inherited myoclonus-dystonia syndrome. Adv Neurol 1998;78:325-334.
2. Quinn NP, Rothwell JC, Thompson PD, Marsden CD. Hereditary myoclonic dystonia, hereditary torsion dystonia and hereditary essential myoclonus: an area of confusion. Adv Neurol 1988;50:391-401.
3. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding ε-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001;29:66-69.
4. Hack AA, Groh ME, McNally EM. Sarcoglycans in muscular dystrophy. Microsc Res Tech 2000;48:167-180.
5. Grimes DA, Han F, Lang AE, St George-Hyslop P, Racacho L, Bulman DE. A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 2002;59:1183-1186.
6. Grimes DA, Bulman D, St George-Hyslop P, Lang AE. Inherited myoclonus-dystonia: evidence supporting genetic heterogeneity. Mov Disord 2001;16:106-110.
7. Klein C, Brin MF, Kramer P, et al. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc Natl Acad Sci USA 1999;96:5173-5176.
8. Leung JC, Klein C, Friedman J, et al. Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 2001;3:133-143.
9. Doheny DO, Brin MF, Morrison CE, et al. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 2002;59:1187-1196.
10. Doheny DO, Danisi F, Smith C, et al. Clinical findings of a myoclonus-dystonia family with two distinct mutations. Neurology 2002;59:1244-1246.
11. Saunders-Pullman R, Shriberg J, Heiman G, et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002;58:242-245.
12. Klein C, Gurvich N, Sena-Esteves M, et al. Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia. Ann Neurol 2000;47:369-373.
13. Garavaglia B, Invernizzi F, Nardocci N, Zorzi G, Girotti F, Zeviani M. Molecular studies of childhood onset primary dystonias in Italy. Am J Hum Genet 2000;67(suppl 2):375.
14. Davies W, Isles AR, Wilkinson LS. Imprinted genes and mental dysfunction. Ann Med 2001;33:428-436.
15. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol 1998;78:1-10.
16. Furukawa Y, Kish SJ. Dopa-responsive dystonia: recent advances and remaining issues to be addressed. Mov Disord 1999;14:709-715.
17. Grötzsch H, Pizzolato G-P, Ghika J, et al. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Neurology 2002;58:1839-1842.
18. Leuzzi V, Carducci Ca, Carducci CI, Cardona F, Artiola C, Antonozzi I. Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome. Neurology 2002;59:1241-1243.
19. Furukawa Y, Guttman M, Sparagana SP, et al. Doparesponsive dystonia due to a large deletion in the GTP cyclohydrolase I gene. Ann Neurol 2000;47:517-520.